Neurofascin-155 as a putative antigen in combined central and peripheral demyelination
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received January 2, 2016
- Accepted in final form April 4, 2016
- First Published June 7, 2016.
Author Disclosures
- Andrea Cortese, MD,
- Jérôme J. Devaux, PhD,
- Elisabetta Zardini, MSc,
- Constance Manso, BSc,
- Guillaume Taieb, MD,
- Clarisse Carra Dallière, MD,
- Philippe Merle, MD,
- Cecilia Osera, PhD,
- Silvia Romagnolo, BSc,
- Nicolò Visigalli, MD,
- Giuseppe Piscosquito, MD,
- Ettore Salsano, MD,
- Enrico Alfonsi, MD,
- Arrigo Moglia, MD,
- Davide Pareyson, MD,
- Enrico Marchioni, MD and
- Diego Franciotta, MD
- Andrea Cortese, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jérôme J. Devaux, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
CSL Behring?s grant in immunology.
NONE
NONE
1) Agence Nationale pour la Recherche (ACAMIN) under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases 2) the Association Fran?aise contre les Myopathies (MNM1 2012-14580)
NONE
NONE
NONE
NONE
NONE
NONE
- Elisabetta Zardini, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Constance Manso, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Guillaume Taieb, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Clarisse Carra Dallière, MD,
NONE
NONE
Travel funded by Merck Serono, TEVA, Novartis
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Philippe Merle, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Cecilia Osera, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Silvia Romagnolo, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nicolò Visigalli, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. Pavia's ASL. I work there as a covering doctor 2.Eupolis Lombardia, as a General pratictioner student
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Giuseppe Piscosquito, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ettore Salsano, MD,
I have served on a scientific advisory board for Actelion Pharmaceuticals Ltd.
NONE
I have received travel expenses from Actelion Pharmaceuticals Ltd.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Enrico Alfonsi, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Arrigo Moglia, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Davide Pareyson, MD,
NONE
NONE
NONE
Journal of Peripheral Nervous System, member of the editorial board (2009-2016) Neurological Sciences, member of the advisory board (2006-2016) Journal of Neuromuscular Disorders, member of the editorial board (2014-2016)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) Pfizer Italia srl (donations for research activities, travels for meeting participation) 2) Kedrion SpA (travels for meeting participation)
1) Regione Lombardia (grant on rare diseases, PI, 2013-2016)
NONE
1) Telethon-UILDM Italy (GUP13006; GUP15009; GUP 15010)
NONE
NONE
NONE
NONE
NONE
NONE
- Enrico Marchioni, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Project Code: RF-2011-02347955 PI: dott. Enrico Marchioni Applicant Institution:Fondazione Istituto Neurologico Casimiro Mondino Project Title: A multicenter prospective study on inflammatory/infectious CNS diseases in different immunological settings: a multidisciplinary approach using an online data base
NONE
grant: PF2007 MIN SAN n. 68
NONE
NONE
NONE
NONE
NONE
NONE
- Diego Franciotta, MD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From IRCCS (A.C., E.Z., C.O., S.R., N.V., E.A., A.M., E.M., D.F.), C. Mondino National Neurological Institute, Pavia, Italy; CNRS (J.J.D., C.M.), CRN2M-UMR 7286, Aix-Marseille Université; Gui de Chauliac Hospital (G.T., C.C.D.), Montpellier University Hospital Center; CHU Amiens-Picardie (P.M.), France; IRCCS Foundation (G.P., E.S., D.P.), C. Besta Neurological Institute, Milan; and University of Pavia (E.Z., A.M.), Italy.
- Correspondence to Dr. Cortese: andrea.cortese{at}mondino.it
Article usage
Cited By...
Letters: Rapid online correspondence
- Response to: Neurofascin-155 as a putative antigen in combined central and peripheral demyelination
- Edgar Meinl, Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilianedgar.meinl@med.uni-muenchen.de
- Atay Vural, Planegg, Germany
Submitted August 01, 2016
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Anti-neurofascin antibody in patients with combined central and peripheral demyelinationNobutoshi Kawamura, Ryo Yamasaki, Tomomi Yonekawa et al.Neurology, July 24, 2013 -
Article
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIgLuis Querol, Gisela Nogales-Gadea, Ricardo Rojas-Garcia et al.Neurology, February 12, 2014 -
Article
Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathyJérôme J. Devaux, Yumako Miura, Yuki Fukami et al.Neurology, February 03, 2016 -
Article
Neurofascin as a target for autoantibodies in peripheral neuropathiesJudy King Man Ng, Joachim Malotka, Naoto Kawakami et al.Neurology, October 24, 2012